Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants
2013
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Exercise training increases size of hippocampus and improves memory
2011 Standout
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
2013 Standout
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
2011
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Monitoring of Lipids, Enzymes, and Creatine Kinase in Patients on Lipid-Lowering Drug Therapy
2013
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
2010 Standout
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants
2016 Standout
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
2015
Abdominal obesity and metabolic syndrome
2006 StandoutNature
A Test in Context: Lipoprotein(a)
2017
National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary
2014
Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150 mg Every Two Weeks Dosing from Phase 2 Trials)
2014
A systematic review of the evidence for Canada's Physical Activity Guidelines for Adults
2010
Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p
2007
Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile
2013
Reference Standards for Cardiorespiratory Fitness Measured With Cardiopulmonary Exercise Testing
2015
Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement
2011
Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
2013 Standout
Assessment of Functional Capacity in Clinical and Research Settings
2007
ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet
2008
The effect of aerobic versus strength-based training on high-sensitivity C-reactive protein in older adults
2010
The Evolving Understanding and Approach to Residual Cardiovascular Risk Management
2020
The metabolic syndrome
2010 Standout
A Mediterranean Diet Is Not Enough for Health: Physical Fitness Is an Important Additional Contributor to Health for the Adults of Tomorrow
2006
Changes in Diet and Lifestyle and Long-Term Weight Gain in Women and Men
2011 Standout
The exercise treadmill test: Estimating cardiovascular prognosis
2008
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Physical activity, fitness and fatness: relations to mortality, morbidity and disease risk factors. A systematic review
2009
Exercise Standards for Testing and Training
2013 Standout
Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis
2011
Exercise Testing in Asymptomatic Adults
2005
Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population
2008
The Prognostic Value of a Nomogram for Exercise Capacity in Women
2005
Effect of school-based physical activity interventions on body mass index in children: a meta-analysis
2009
The changing landscape of atherosclerosis
2021 StandoutNature
Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group
2014
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
2009
Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
2012
Physical Activity and Weight Gain Prevention
2010
Guidelines for the Primary Prevention of Stroke
2010
Global Risk Scores and Exercise Testing for Predicting All-Cause Mortality in a Preventive Medicine Program
2004
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
2009 Standout
Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
2010
Impact of Physical Activity, Cardiorespiratory Fitness, and Exercise Training on Markers of Inflammation
2011
Obesity
2005 Standout
Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy
2016
Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
2017
Triglycerides and cardiovascular disease
2014
Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study
2012
Physical fitness in childhood and adolescence: a powerful marker of health
2007 Standout
Triglycerides on the rise: should we swap seats on the seesaw?
2014
The influence of sex on the relationship between heart rate recovery and other cardiovascular risk factors in apparently healthy subjects
2009
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women
2007
Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management
2018
Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain
2020 StandoutNobel
Anti-aging therapy through fitness enhancement
2006
Ventricular Arrhythmias During Clinical Treadmill Testing and Prognosis
2008
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
2012
Lipoprotein Management in Patients With Cardiometabolic Risk
2008
Aerobic Exercise and Neurocognitive Performance: A Meta-Analytic Review of Randomized Controlled Trials
2010 Standout
Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A review
2011
External Prognostic Validations and Comparisons of Age- and Gender-Adjusted Exercise Capacity Predictions
2007
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
2014
Longitudinal Algorithms to Estimate Cardiorespiratory Fitness
2014
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
2010
The effectiveness of personalized coronary heart disease and stroke risk communication
2011
El perfil lipídico-metabólico en los adolescentes está más influido por la condición física que por la actividad física (estudio AVENA)
2007
Clinician-Patient Risk Discussion for Atherosclerotic Cardiovascular Disease Prevention
2015
Exercise Training as Vascular Medicine
2009
Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women
2009 Standout
Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial
2013
Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular Risk Reduction in Randomized Trials
2012
Atherosclerosis
2019 Standout
The Discovery and Development of Liraglutide and Semaglutide
2019
A Potential Decline in Life Expectancy in the United States in the 21st Century
2005 Standout
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Diabetes: A Meta-Analysis
2010
Cardiorespiratory Fitness as a Predictor of Nonfatal Cardiovascular Events in Asymptomatic Women and Men
2007
The predictive value of cardiorespiratory fitness combined with coronary risk evaluation and the risk of cardiovascular and all‐cause death
2007
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
2012
Estimated Functional Capacity Predicts Mortality in Older Adults
2007
Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy
2012 Standout
Gender differences in the prognostic value of exercise treadmill test characteristics
2011
Mejora de la forma física como terapia antienvejecimiento
2005
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Reliability and validity of the combined heart rate and movement sensor Actiheart
2005
Should people at low risk of cardiovascular disease take a statin?
2013
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Evolution and Functions of Long Noncoding RNAs
2009 Standout
Cardiorespiratory Fitness in Young Adulthood and the Development of Cardiovascular Disease Risk Factors
2003
Mortality and Cardiovascular Events in Patients Treated With Homocysteine-Lowering B Vitamins After Coronary Angiography
2008
Exercise and vascular adaptation in asymptomatic humans
2010
Cardiorespiratory Fitness Is Related to the Risk of Sudden Cardiac Death
2010
Drugs Targeting High-Density Lipoprotein Cholesterol for Coronary Artery Disease Management
2012
A non-exercise testing method for estimating cardiorespiratory fitness: associations with all-cause and cardiovascular mortality in a pooled analysis of eight population-based cohorts
2012
Relationship of Physical Fitness vs Body Mass Index With Coronary Artery Disease and Cardiovascular Events in Women
2004
The predictive value of cardiorespiratory fitness for cardiovascular events in men with various risk profiles: a prospective population-based cohort study
2004
Frailty in elderly people
2013 Standout
Effects of Different Doses of Physical Activity on Cardiorespiratory Fitness Among Sedentary, Overweight or Obese Postmenopausal Women With Elevated Blood Pressure
2007
Fibrates Effect on Cardiovascular Risk Is Greater in Patients With High Triglyceride Levels or Atherogenic Dyslipidemia Profile: A Systematic Review and Meta-analysis
2010
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Anthropometric Determinants of a Clustering of Lipid-Related Metabolic Risk Factors in Overweight and Non-Overweight Adolescents – Influence of Cardiorespiratory Fitness
2006
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Real-World Evidence — What Is It and What Can It Tell Us?
2016 Standout
Role of Frailty in Patients With Cardiovascular Disease
2009
Effects of a Plant-Based High-Carbohydrate/High-Fiber Diet Versus High–Monounsaturated Fat/Low-Carbohydrate Diet on Postprandial Lipids in Type 2 Diabetic Patients
2009
Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study
2011
Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged men: a randomized-controlled trial
2009
Bajo nivel de forma física en los adolescentes españoles. Importancia para la salud cardiovascular futura (Estudio AVENA)
2005
Routine Assessment and Promotion of Physical Activity in Healthcare Settings: A Scientific Statement From the American Heart Association
2018
Cardiorespiratory Fitness and Long‐Term Survival in “Low‐Risk” Adults
2012
Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: effect of endurance exercise training
2009
Statins for primary prevention of venous thromboembolism
2014
Review: Mortality trends in the general population: the importance of cardiorespiratory fitness
2010
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction
2012
Physical Activity and Cardiovascular Health
2010
Atherosclerosis Drug Development in Jeopardy: The Need for Predictive Biomarkers of Treatment Response
2011
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
Hypertriglyceridemia in the Genomic Era: A New Paradigm
2015
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force
2009
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol
2017
Low Level of Physical Fitness in Spanish Adolescents. Relevance for Future Cardiovascular Health (AVENA Study)
2005
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
Exercise and Physical Activity
2010
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
The importance of cardiorespiratory fitness for healthy metabolic traits in children and adolescents: the AVENA Study
2006
Guidelines for the Primary Prevention of Stroke
2014 Standout
Are There Genetic Paths Common to Obesity, Cardiovascular Disease Outcomes, and Cardiovascular Risk Factors?
2015
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
2016
THE PROGNOSTIC VALUE OF A NOMOGRAM FOR EXERCISE CAPACITY IN WOMEN
2005
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
Increased Cardiovascular Risk in Hypertriglyceridemic Patients With Statin-Controlled LDL Cholesterol
2018
Exercise Capacity and Mortality in Hypertensive Men With and Without Additional Risk Factors
2009
The National Physical Activity Plan: A Call to Action From the American Heart Association
2015
Can Noncommunicable Diseases Be Prevented? Lessons from Studies of Populations and Individuals
2012 Science
Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2014 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline
2015
The Importance of Cardiorespiratory Fitness in the United States: The Need for a National Registry
2013
Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force
2009
Exercise Capacity and Mortality in Black and White Men
2008
Statins for the primary prevention of cardiovascular disease
2013
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Relations of total physical activity and intensity to fitness and fatness in children: the European Youth Heart Study1–3
2006
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
2013
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia
2017
Association of serum lipid indices with large artery atherosclerotic stroke
2007
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
2011
Implications of the US Cholesterol Guidelines on Eligibility for Statin Therapy in the Community: Comparison of Observed and Predicted Risks in the Framingham Heart Study Offspring Cohort
2015
Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque
2018
Usefulness of Exercise Testing in the Prediction of Coronary Disease Risk Among Asymptomatic Persons as a Function of the Framingham Risk Score
2004
Physical Activity, Cardiorespiratory Fitness, and Exercise Training in Primary and Secondary Coronary Prevention
2013
Nonfasting Lipids, Lipoproteins, and Apolipoproteins in Individuals with and without Diabetes: 58 434 Individuals from the Copenhagen General Population Study
2010
Exercise Stress Testing in Women
2010
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
2010
Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease
2016
A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk
2011
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
2012
Lifestyle Modification for Obesity
2012
Fasting and Nonfasting Lipid Levels
2008
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
2020
Metabolic Syndrome: A Clinical and Molecular Perspective
2004
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
2013 Standout
Cardiorespiratory Fitness and Classification of Risk of Cardiovascular Disease Mortality
2011
Assessment of omega‐3 carboxylic acids in statin‐treated patients with high levels of triglycerides and low levels of high‐density lipoprotein cholesterol: Rationale and design of the STRENGTH trial
2018
How Common Is Residual Inflammatory Risk?
2017
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Physical activity: the missing prescription
2005
Lipoprotein(a): resurrected by genetics
2012
Cholesterol Synthesis Inhibition Elicits an Integrated Molecular Response in Human Livers Including Decreased ACAT2
2008 StandoutNobel
Novel Antiatherosclerotic Therapies
2019
Importance of Treadmill Exercise Time as an Initial Prognostic Screening Tool in Patients With Systolic Left Ventricular Dysfunction
2009
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Further Insight Into the Cardiovascular Risk Calculator
2014
Traditional and novel cardiovascular risk factors in school-aged children: A call for the further development of public health strategies with emphasis on fitness
2007
Primary prevention of cardiovascular events in patients with major mental illness: a possible role for statins
2013
Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin‐controlled LDL cholesterol
2018
Cardiorespiratory fitness is associated with features of metabolic risk factors in children. Should cardiorespiratory fitness be assessed in a European health monitoring system? The European Youth Heart Study
2006
Cardiopulmonary Fitness and Heart Rate Recovery as Predictors of Mortality in a Referral Population
2014
Validation of the Friedewald Formula in Patients with Metabolic Syndrome
2014
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Aging and brain rejuvenation as systemic events
2014
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
2018
The Future of Aerobic Exercise Testing in Clinical Practice: is It the Ultimate Vital sign?
2010
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
2020
Works of Samia Mora being referenced
Safety Profile of Subjects Treated to Very Low Low-Density Lipoprotein Cholesterol Levels (<30 mg/dl) With Rosuvastatin 20 mg Daily (from JUPITER)
2014
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial
2010
Clinical implications of discordance between low-density lipoprotein cholesterol and particle number
2011
Weighing the Anti-Ischemic Benefits and Bleeding Risks from Aspirin Therapy: a Rational Approach
2018
Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study
2007
Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis
2009
LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)
2006
Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents
2016
Impact of High-Dose Atorvastatin Therapy and Clinical Risk Factors on Incident Aortic Valve Stenosis in Patients With Cardiovascular Disease (from TNT, IDEAL, and SPARCL)
2014
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
2018
Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women
2007
On-Treatment Non–High-Density Lipoprotein Cholesterol, Apolipoprotein B, Triglycerides, and Lipid Ratios in Relation to Residual Vascular Risk After Treatment With Potent Statin Therapy
2012
Ability of Exercise Testing to Predict Cardiovascular and All-Cause Death in Asymptomatic Women
2003
Association of Physical Activity and Body Mass Index With Novel and Traditional Cardiovascular Biomarkers in Women
2006
AHA/ACCF 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults
2009
The use of high-sensitivity assays for C-reactive protein in clinical practice
2008
Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease
2016
Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk
2013
Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease
2016
Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women
2009
Physical Activity and Reduced Risk of Cardiovascular Events
2007
Comparison of LDL Cholesterol Concentrations by Friedewald Calculation and Direct Measurement in Relation to Cardiovascular Events in 27 331 Women
2009
Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events
2008
Lipoprotein(a) and Risk of Type 2 Diabetes
2010
Elevated C-reactive protein in high-risk asymptomatic individuals is strongly associated with the metabolic syndrome
2003
Enhanced Risk Assessment in Asymptomatic Individuals With Exercise Testing and Framingham Risk Scores
2005
Advanced Lipoprotein Testing and Subfractionation Are Not (Yet) Ready for Routine Clinical Use
2009
Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study
2004
Interaction of Body Mass Index and Framingham Risk Score in Predicting Incident Coronary Disease in Families
2005
Homocysteine, 5,10-Methylenetetrahydrofolate Reductase 677C>T Polymorphism, Nutrient Intake, and Incident Cardiovascular Disease in 24 968 Initially Healthy Women
2007
Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol
2017
Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia
2010
Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women’s Health Initiative
2018
Exercise Blood Pressure and Future Cardiovascular Death in Asymptomatic Individuals
2010
Discordance of Low-Density Lipoprotein (LDL) Cholesterol With Alternative LDL-Related Measures and Future Coronary Events
2013
Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study
2012
Fasting for Lipid Testing: Is It Worth the Trouble?
2012
Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events
2017
The Guidelines Battle on Starting Statins
2014
Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
2012
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
2018
The Clinical Utility of High-Sensitivity C-Reactive Protein in Cardiovascular Disease and the Potential Implication of JUPITER on Current Practice Guidelines
2008
Determinants of Residual Risk in Secondary Prevention Patients Treated With High- Versus Low-Dose Statin Therapy
2012
Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
2018
High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy
2013
Additive Value of Immunoassay-Measured Fibrinogen and High-Sensitivity C-Reactive Protein Levels for Predicting Incident Cardiovascular Events
2006
ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults
2009